US 9957526
Delivery methods and compositions for nuclease-mediated genome engineering
granted A61PA61P43/00
Quick answer
US patent 9957526 (Delivery methods and compositions for nuclease-mediated genome engineering) held by Sangamo Therapeutics, Inc. expires Mon Apr 26 2038 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Sangamo Therapeutics, Inc.
- Grant date
- Tue May 01 2018 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Apr 26 2038 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 7
- CPC classes
- A61P, A61P43/00